Main Menu

News and features 

Read the latest stories about our world-leading research, science, fundraising and philanthropy

To find out more, you can contact our media team, follow us on social media or visit our press release archive.

Sign up for our newsletters


Ride announced in memory of Hairy Biker Dave Myers to support The Institute of Cancer Research 15

The Institute of Cancer Research, London, is honoured to be a beneficiary of a motorbike ride in tribute to Dave Myers of the Hairy Bikers. The ride will take place on Saturday 8 June 2024. Find out more

Scientists find new ways to convert inhibitors into degraders, paving the way for future drug discoveries 11

Researchers have discovered ways to convert inhibitor-style targeted cancer drugs into small molecules known as degraders, which help destroy cancer-promoting proteins in cells. Find out more

Groundbreaking methodological advance will support the design of innovative new cancer drugs 10

Scientists have successfully used a new imaging technique to determine the structure and interactions of a protein complex that plays a significant part in the initiation and progression of cancer. Find out more

See all news articles


Scientific achievements of 2023 05

We've selected a range of discoveries from the academic year that highlight the quality and breadth of our basic, translational and clinical research. Find out more

Untapping the full potential of immunotherapies for more people with cancer 06

Immunotherapy works by sparking the body’s own immune system into action against tumours. It has become a first-choice treatment for some types of cancer, and now there are exciting opportunities to unlock its benefits for more patients through research. Jane Shepley explores the story behind immunotherapy and how we can untap its potential. Find out more

Over a decade of abiraterone: the drug that revolutionised advanced prostate cancer care 14

This Prostate Cancer Awareness Month, we’re celebrating over 10 years since abiraterone was first recommended by NICE in England as a treatment for advanced prostate cancer. We share the story of the drug’s discovery, how a landmark trial changed the way advanced prostate cancer is treated today, and what the drug has meant for patients who are currently treated with it. Find out more

See all feature articles